TheNote
FDA Approves First Treatment f... Note
GooglePlay AppStore
FDA | Press Releases

FDA Approves First Treatment for Patients with Cerebral Folate Transport Deficiency

The U.S. Food and Drug Administration today approved expanded use of Wellcovorin (leucovorin calcium) tablets for the treatment of cerebral folate deficiency in adult and pediatric patients who have a confirmed variant in the folate receptor 1 gene (CFD-FOLR1).
http://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-patients-cerebral-folate-transport-deficiency fda.gov
RSS Hunter RSS Hunter • Mar 10